Pilot trial suggests structured support may help limit weight regain after GLP-1 treatment

Дата публикации: 07-10-2026 07:10:01

Glucagon-like peptide-1 (GLP-1) receptor agonists are effective treatments for obesity, but discontinuation is common due to cost, insurance coverage limitations, side effects, patient preference and other factors—and often leads to rapid weight regain. Results from a pilot randomized trial, published in Obesity Science & Practice, suggest that structured support may attenuate early weight gain after GLP-1 cessation.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Researchers aim to mitigate weight gain after stopping GLP-1 use	0	13.57	14-10-2026
2	Researchers aim to mitigate weight gain after stopping GLP-1 use	0	13.57	14-10-2026
3	Time-Dependent Effects of GLP-1 Receptor Agonists on Weight Loss: A Systematic Review and Meta-Analysis of Phase 3 Trials [version 1; peer review: awaiting peer review]	0	13.63	08-08-2026
4	New GLP-1 pill delivers up to 12% weight loss in 36 weeks	0	11.64	10-08-2026
5	Women more often hired after losing weight on GLP-1s: Study	0	5	03-07-2026
6	Unexpected GLP-1 side effect? Studies show the meds may help people with addictions	0	8.21	23-08-2026
7	Dispelling Myths Around GLP-1 Medications	0	9.15	24-09-2026
8	Role of Liraglutide in Weight Management and Reproductive Health in Women with Obesity and PMOS- A Critical Review of the Evidence [version 3; peer review: 2 approved]	0	6.46	06-08-2026
9	7 Surprising Benefits Of GLP-1s That Are Not About Weight Loss	0	11.82	10-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.76. Источник: medicalxpress.com.